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Objectives: MEETINGDEM investigated whether the Dutch Meeting Centres Support Programme 
(MCSP) could be implemented in Italy, Poland, and the UK with comparable benefits. This paper reports 
on the impact on people living with dementia attending pilot Meeting Centres in the 3 countries. 
Methods: Nine pilot Meeting Centres (MCs) participated (Italy—5, Poland—2, UK—2). Effec- 
tiveness of MCSP was compared with Usual Care (UC) on outcomes measuring behavioural 
and psychological symptoms (NPI), depression (CSDD), and quality of life (DQoL, QOL-AD), 
analysed by ANCOVAs in a 6-month pre-test/post-test controlled trial. 
Results: Pre/post data were collected for 85 people with dementia and 93 carers (MCSP) and 
74 people with dementia /carer dyads' receiving UC. MCSP showed significant positive effects 
for DQoL [Self-esteem (F = 4.8, P = 0.03); Positive Affect (F = 14.93, P < 0.00); Feelings of Belong- 
ing (F = 7.77, P = 0.01)] with medium and large effect sizes. Higher attendance levels correlated 
with greater neuropsychiatric symptom reduction (rho = 0.24, P = 0.03) and a greater increase in 
feelings of support (rho = 0.36, P = 0.001). 
Conclusions: MCSPs showed significant wellbeing and health benefits compared with UC, 
building on the evidence of effectiveness from the Netherlands. In addition to the previously 
reported successful implementation of MCSP in Italy, Poland, and the UK, these findings suggest 
that further international dissemination of MCSP is recommended. 
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 1 |    INTRODUCTION  
 
Many national dementia strategies recommend the early and timely 
diagnosis of dementia. Earlier diagnosis provides the opportunity for 
people to make lifestyle changes and choices that will build resilience 
for the long term. However, people often feel overwhelmed and con- 
fused about where to get help. Relatively few interventions exist that 
focus on supporting both the person diagnosed with dementia and 
their family carer, whereas evidence suggests that combined interven- 
tions are often more beneficial than single interventions.1-3 The Meet- 
ing Centres Support Programme (MCSP) is a way of providing 
accessible support on a local level that focuses on both the person liv- 
ing with dementia and their family. The MCSP is a way of providing 
accessible early support on a local level and provides a means of meet- 
ing the needs of people in the post-diagnostic stage. MCSP was devel- 
oped, in collaboration with people with dementia and carers, following 
a community needs assessment in the Netherlands 25 years ago.4,5 
Typically, MCSP serves a local community of around 5000 older peo- 
ple. The Meeting Centre (MC) “club” is offered 3 days per week, 
supporting 10 to 15 people plus families in easily accessible commu- 
nity locations. Evidence-based post-diagnostic psychosocial interven- 
tions are provided in a friendly manner, tailored to the needs of the 
local members. This is facilitated by a small team of staff and volun- 
teers trained in the ethos of person centred dementia care, informed 
by the Adaptation-Coping Model.6,7 Carers (the principal caregiver, 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
their family carers to ascertain if the results were comparable with 
those found in the Netherlands. Participants reported high levels of 
14 
ie, the person most involved in the care which maybe the partner, a satisfaction with the support provided. In this paper, we focus on 
son or daughter, but also a friend or acquaintance) can get practical 
information, personal advice and emotional, social contact, and peer 
support. The local focus helps local agencies to collaborate effectively 
in helping people live well with dementia, thus counteracting the frag- 
mentation of care. 
In 2 Dutch multi-centre effect studies comparing people attending 
MCs with those attending regular day care, people utilising MCs 
displayed fewer behaviour problems, in particular less non-social 
behaviour and inactive behaviour, after 7 months.4,8 Furthermore, 
there was a positive effect on depressive behaviour and self-esteem 
for people with dementia and also benefits for family carers.5,9 
Research in the Netherlands identified various factors that promoted 
successful implementation of MCSP.10 An implementation guide, pub- 
lications, films, and a training course for staff assisted organisations to 
set up MCSPs supported by a national helpdesk. As a result, MCSPs 
have spread across the country with more than 145 MCs in the Neth- 
erlands supporting 5500 people and their carers annually. 
This paper reports on the JPND project MEETINGDEM11 that 
aimed to transfer MCSP to Italy, Poland, and the UK, to investigate 
whether adaptations were needed to support successful implementa- 
tion in these countries, and to evaluate if comparable benefits could 
be achieved. The adaptive implementation involved translating MCSP 
concepts and practicalities into a new country context. After exploring 
pathways to care,12 pilot MCs were successfully implemented in all 
countries in 2015 following a 12-month period of collaborative com- 
munity engagement and adaptation.13 Within each participating coun- 
try, a national project team conducted a standardised implementation 
study and assessed the impacts on people living with dementia and 
the impact of MCSP on social, behavioural, and emotional functioning 
of people living with dementia. 
 
 
2 |    METHOD  
 
2.1 |  Design 
As with the original Dutch Effect study, a pre/post-test control group 
design was used comparing outcomes for people with dementia and 
family carers attending the MCSP with a Usual Care (UC) control group 
on several outcome measures. Measures were taken at pre-test (within 
1 month of starting to attend the MC or UC) and again after 6 months. 
Taking into account attrition of 15% over this period, it was deter- 
mined that 75 persons with dementia/family carer dyads should be 
recruited to each arm (Total 150; 25 per arm in each of the 3 coun- 
tries). This number was based on the results of previous effect studies 
into MCSP, in which moderate to large effects were found, and a 
power calculation: to demonstrate moderate effects (d = 0.5), with a 
power of 0.80 and alpha 0.05. Changes over time that may have 
impacted on the outcomes (illness, physical disability, significant med- 
ication changes, and the use of other types of support) were moni- 
tored. Reasons for drop out and life events were also recorded. The 
research underwent ethical review in the separate countries and was 
approved. 
 
2.2 | Participants 
The main target group for the MCSP were people with mild to moder- 
ately severe dementia, living at home, and having a carer prepared to 
 
Key points 
 
• The Meeting Centres Support Programme (MCSP) was 
developed in the Netherlands 25 years ago to provide 
local community support both to people living with 
dementia and their family carers. It has proven benefits 
and now supports nearly 5500 people per year across 
the Netherlands. 
• Meeting Centres were successfully implemented in Italy, 
Poland, and the UK utilising the Dutch model and 
adapting MCSP to country specific needs and contexts 
• After 7 months attending the Meeting Centres people 
living with dementia reported significant improvements 
in self-esteem, positive affect and feelings of 
belonging. Higher levels of attendance were correlated 
with a greater reduction in distressing behaviour 
symptoms and greater feelings of support. 
• The MCSP is transferable across different countries and 
shows benefits for people living with dementia at home. 
 
participate in the MCSP. There were no exclusions on age or type of 
dementia. Both people with dementia and carers self-reported on out- 
comes but carers also reported their perceptions of the social and 
emotional functioning of the person living with dementia. A separate 
paper details the impact on family carer outcomes measures.15 
 
2.3 | Meeting Centres Support Programme 
intervention 
Pilot MCs were successfully provided in specific geographic local com- 
munities in all 3 countries during 2015 to 2016, following a 12-month 
period of collaborative community engagement and preparatory work 
according to the Dutch step-wise implementation procedure.13 This 
included 5 MCs in Italy (Lombardia and Emilia-Romagna regions), 2 in 
Poland (Wroclaw region), and 2 in the UK (Central England). It was 
not possible to explore the impact of all regions and jurisdictions within 
the countries. Materials and concepts developed in the Netherlands 
were translated. Compliance with the original MCSP model was main- 
tained to a high degree, although several country adaptations were 
made, such as more flexibility of attendance to the programme accord- 
ing to need, severity of dementia of the target group, and additional 
therapeutic approaches.12 The MC “club” was offered 3 days per week 
in the UK and Poland and 3 half-days to 2 days per week in Italy. A 
total of 10 to 15 dyads (people with dementia/family members) were 
supported per day. Participants for the research (MCSP group) were 
recruited from people with dementia planning to attend the MC at 
least 1 day per week. 
 
2.4 |  Usual Care 
Within the original Dutch research, the UC group consisted of partici- 
pants of Psychogeriatric Day Care units within Nursing homes and 
their carers. In the current study, the UC participants were recruited 
from a cohort group on a similar part of the dementia pathway within 
the same locality but outside the MC catchment area. 
 
2.5 |  Measures 
Background information on age, education level, and gender was col- 
lected for all participants alongside (at pre- and posttest) information 
on individual factors (comorbidities, physical disability, psychotropic 
drug use, life events, use of other types of support) that may have 
influenced outcomes. The Global Deterioration Scale (GDS)16 was 
used to determine severity of dementia on a 7-stage scale, the EQ- 
5D (mobility) as an indication for physical disability. Three of the 
standardised measures which were utilised in the original Dutch 
effects study were used in the current study to assist with comparison. 
The DQoL17 is a 30-item interview used with the persons with mild to 
moderate dementia to assess the impact on quality of life, consisting of 
5 subscales showing good internal consistency and test-retest reliabil- 
ity. All subscales are scored so that a higher score indicates a better 
quality of life. The Cornell Scale for Depression in Dementia (CSDD)18 
is a 19-item rating scale for assessing symptoms of depression in per- 
sons with dementia, observed in the week prior to the assessment. The 
Neuropsychiatric Inventory (NPI-Q)19,20 assesses dementia-related 
behavioural, mood, and psychiatric symptoms. The severity of the 
symptoms and distress for the caregiver were assessed. In addition, 
the 13-item structured interview QOL-AD21 was included as it can 
be answered by people with more advanced dementia.22 The Duke 
Social Support Inventory (DSSI)23 was used to assess feelings of social 
support. 
The Polish versions of the NPI-Q24 and the GDS25 were used. The 
Italian versions of the NPI-Q26 and the QOL-AD27 were used. An 
existing Italian version of the GDS was utilized, but there have been 
no papers published on its validation. All measures for which no trans- 
lation was available in Italian or Polish were translated and adapted 
according to WHO formal criteria for questionnaires.28 Back transla- 
tion of the Polish versions of the GDS, DQoL, CSDD, QOL-AD, and 
DSSI and back translations of the Italian versions of the DQoL, CSDD, 
and DSSI were undertaken to ensure fidelity. 
 
 
2.6 | Procedures 
A strong project management focus was employed throughout to 
ensure fidelity of the intervention to the original Dutch model and to 
maximise standardisation of research procedures across the different 
countries. Annual face-to-face meetings and monthly teleconferences 
occurred throughout the 3-year project. All MCSP members were 
invited to participate in the research by the MC Manager within the 
first 2 weeks of attendance. Participation in the research was entirely 
voluntary. For ethical and pragmatic reasons, it was not possible to 
undertake baseline measures prior to MC attendance. The DQoL, 
QOL-AD, and DSSI were administered by the researchers during an 
interview with the person with dementia. The NPI-Q was completed 
by the family carers. The GDS and CSDD were completed by the MC 
managers through interviews with the person with dementia and the 
family carer. Meeting Centre managers received training from the 
research team to do this. Italian, Polish, and English versions of mea- 
sures and interviews were used. Participants who dropped out of the 
MC before post-test data collection were not included in the effect 
evaluation. For the UC group, all measures were administered by 
researchers in participants' own homes and the GDS and CSDD com- 
pleted by a professional who knew the person. Follow-up data were 
collected using the same measures 6 months after the baseline data 
collection point. 
 
 
2.7 |  Data analysis 
The aim of the analysis was to explore whether similar effects were 
found for these adaptively implemented MCs as had been found 
within the original Dutch effect study.4 The current trial was explor- 
atory in nature, being conducted during the cross country implementa- 
tion study. Given the exploratory nature of the trial, and consequently 
the relatively small sample per country, a decision was made to run the 
same analyses as in the Netherlands and thus to do separate 
ANCOVA's with a P-value of 0.05 and to not apply a Bonferroni cor- 
rection on each test because of multiple testing. This enabled us to 
make more direct comparisons with the original Dutch research and 
to evaluate the feasibility of MCSP in other European countries. Fol- 
lowing a similar process to that adopted in the Dutch study,4 the base- 
line characteristics of the participants in the MCSP and UC groups 
 
were analysed descriptively with differences between the groups 
being tested (2-sided, alpha 0.05) by using t-tests (for ordinal and inter- 
val data that were normally distributed) and Chi2 tests (for nominal 
data). ANCOVA's and t-tests were used on the outcome measures data 
that had normal distribution. t-tests and Chi2 tests were undertaken to 
assess whether the MCSP intervention and UC control groups differed 
at baseline on characteristics such as gender, age, degree of dementia 
etc. Characteristics that differed significantly between the MCSP and 
UC at baseline and correlated with 1 or more outcome measure 
(potential confounding variables) were included as covariates in the 
analysis. The outcome measures data were analysed by covariance 
analyses (ANCOVAs) on the post-test measurements that included 
baseline measurements as covariates in the analysis. The data overall 
(all countries) were combined to assess differences between the MCSP 
and UC groups. Although the study was not sufficiently powered to 
fully test differences per country and between countries, we explored 
some of the differences between MCSP and UC groups at a country 
level (within the countries). 
The ANCOVA analysis was conducted using the statistical pack- 
age SPSS Version 23, where the options were selected to report the 
adjusted means and effect size in each case. Cohen's d effect sizes29 
were calculated for each ANCOVA. By using records of medication 
use, reported illness/significant life events for participants in the 
weeks before the post test, and use of other care and support services, 
it was assessed as to whether psychotropic medication, illness or life 
events, or the use of other types of support had influenced outcomes 
on a group basis. Spearman's rank correlation was undertaken on the 
outcome measures and attendance levels to further explore the effect 
of attendance on changes in outcomes over time for the MCSP group. 
 
 
3 |   RESULTS 
 
3.1 | Numbers recruited to research 
The numbers originally recruited, data collected at pre-test and post- 
test by country, are shown in Figure 1. Between pre-test and post-test 
measures, there was attrition of 27% in the MCSP group and 18% in 
the UC group. Those who dropped out tended to be slightly older 
and have more severe dementia. There were no significant character- 
istic differences in attrition between MCSP and UC groups. Data anal- 
ysis was based on completed measures from 85 people with dementia 
attending the MC across Italy, Poland, and the UK, and 74 people with 
dementia receiving UC. 
Recruitment to the MCSP group was through the MCs in the 
respective countries. Recruitment to the UC group was through health 
or welfare organisations (UK 3/41; Italy 15/25; Poland 17/24) or 
through GPs (UK 0/41; Italy 0/25; Poland 4/24) or through non-gov- 
ernmental/charitable support services (UK 31/41; Italy 10/25; Poland 
1/24). A small number were recruited through other contacts (UK7/41; 
Italy 0/25; Poland 2/24). 
 
3.2 |  Participant characteristics 
There were no significant differences between the participant charac- 
teristics in those recruited to either MCSP or UC (Table 1). 
3.3 | Comparison of outcome measures for MCSP 
and UC 
ANCOVAs were performed on all outcome measures overall and per 
country. Overall ANCOVAs and country specific results are 
summarised in Table 2. Severity of Dementia according to the GDS cat- 
egories of Mild, Moderate, and Severe were included as an additional 
fixed factor within the analysis. 
 
 
3.3.1 |   Quality of life 
The ANCOVA results indicate that compared with the UC group, the 
MCSP group benefitted most on quality of life (DQoL). Significant dif- 
ferences were recorded on the domains self-esteem, positive affect, 
and feelings of belonging, with medium to large effect sizes. There 
was a clear pattern within the DQoL scores either remaining stable 
or improving for the MCSP group over time whereas the pattern was 
much more mixed in the UC group. The ANCOVA did not show a sta- 
tistically significant difference between the scores for the MCSP and 
UC groups on the QOL-AD for the countries overall. 
 
 
3.3.2 |  Depression 
The ANCOVA did not show a significant difference between MCSP 
and UC for the CSDD. 
 
 
3.3.3 |   Neuropsychiatric symptoms 
The ANCOVA did not show a significant difference between MCSP 
and UC at post-test. There were some differences in the changes in 
types of symptoms reported by the 2 groups over time (Table 3). There 
was an 11% increase in agitation for the UC group, whereas the MCSP 
group experienced a 7% reduction. The UC group showed a 10% 
increase in apathy, whereas the MCSP group only experienced a 2% 
increase. However, the changes were not all in a positive direction 
for the MCSP group. For example, the UC group experienced a 6% 
reduction in sleep disturbance, whereas the MCSP group experienced 
a 7% increase. Whilst these cannot be taken as evidence of effect of 
the intervention, they are of interest in that they provide a picture of 
the prevalence of these symptoms in both groups and the change in 
6 months. 
Feeling of Support: No significant difference between MC and UC 
groups was found for any of the sub-domains of the DSSI. 
 
 
3.4 |  MC attendance 
 
How people utilised MCSP varied according to individual needs with 
some people utilising MCSP at every opportunity whereas others were 
infrequent users. The mean number of days' attendance over 6 months 
is shown in Table 4 overall and by countries. Secondary analysis using 
Spearman's rank correlation between frequency of attendance and the 
changes in outcome measures demonstrated a significant correlation 
between higher attendance and more positive changes in symptom 
severity on the NPI (rho = 0.24, P = 0.03). There was also a significant 
correlation between higher attendance and a greater change in Duke 
SSI sub-domain of feelings of support (rho = 0.36, P = 0.001). 
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FIGURE 1 Numbers of research participants 
with dementia recruited to the Meeting 
Centres Support Group and the Usual Care 
Group by country and completing assessments 
at each stage [Colour figure can be viewed at 
wileyonlinelibrary.com] 
 
 
TABLE 1  Data on persons with dementia using the Meeting Centres Support Programme (MCSP) and receiving Usual Care (UC) 
  MCSP Group (n = 85) UC Group (n = 74) Test Statistic P (2-Sided)  
Sex Male 36 (42.4%) 34 (45.9%) χ2 = 0.21 0.65 
Female 49 (57.6%) 40 (54.1%) 
 
 
 
 70–79 27 (32.5%) 34 (46.6%)  
80+ 41 (49.4%) 32 (43.8%) 
Civil status Married/co-habiting/ civil partnership 48 (56.5%) 48 (66.7%) χ2 = 1.71 0.19 
 Widowed/divorced/ single 37 (43.5%) 24 (33.3%)   
Severity of dementia (GDS score) Mean score (standard deviation) 4.0 (1.1) 3.7 (1.1) t = 1.98 0.11 
 Median score (range) 4 (2–7) 4 (1–6)   
Primary care giver Spouse/partner 45 (52.9%) 43 (58.1%) χ2 = 3.14 0.21 
 Daughter/son 30 (35.3%) 28 (37.8%)   
 Other 10 (11.8%) 3 (4.1%)   
TABLE 2 Outcome measures and results of ANCOVAs using pre-test and post-test means for Meeting Centre Support Programme (MCSP) and 
Usual Care (UC) groups 
Measure 
(Numbers 
  Pre-Test 
MCSP 
 
 
UC mean 
Post-Test 
MCSP 
 
 
UC mean 
Post-Test 
ANCOVA Adjusted 
   
 
Effect 
in MCSP/UC)   mean (SD) (SD) mean (SD) (SD) MC/UC Mean F P Size d 
D-QOL Sense of Overall (n = 82/69) 18.3 (3.6) 17.7 (5.1) 19.4 (3.8) 18.6 (5.2) 18.8/18.3 0.56 0.46 0.13 
sub domains aesthetics Italy (n = 37/20) 18.3 (3.7) 16.4 (4.5) 19.8 (4.1) 17.1 (4.6) 20.5/18.8 2.19 0.15 0.41 
(range of (5–25) Poland (n = 19/18) 18.1 (3.3) 18.3 (4.5) 19.0 (3.1) 18.6 (3.6) 19.1/18.5 0.35 0.56 0.20 
scores)  UK (n = 26/31) 18.6 (4.0) 18.3 (5.8) 19.1 (4.0) 19.6 (6.3) 18.5/18.6 0.03 0.87 0.06 
 Self-esteem Overall 13.5 (3.4) 13.4 (2.8) 14.3 (3.1) 13.1 (3.7) 14.2/13.1 4.80 0.03* 0.38 
 (4–20) (n = 78/65)         
  Italy (n = 35/20) 14.5 (3.3) 13.0 (2.3) 15.4 (2.8) 13.3 (2.6) 15.4/13.8 3.76 0.06 0.55 
  Poland (n = 19/18) 12.5 (3.3) 13.5 (2.9) 13.6 (2.7) 14.1 (3.7) 13.9/13.7 0.07 0.80# 0.09 
        [0.17] [0.69] 0.14 
  UK (n = 24/27) 12.9 (3.3) 13.7 (3.1) 13.1 (3.3) 12.4 (4.3) 13.4/11.8 2.39 0.13 0.45 
 Positive affect Overall (n = 80/67) 20.5 (4.4) 22.0 (4.9) 21.9 (4.3) 20.6 (3.9) 22.0/19.9 14.93 0.00* 0.65 
 (6–30) Italy (n = 37/20) 20.6 (4.7) 22.2 (3.8) 22.7 (4.0) 20.1 (3.9) 23.1/19.4 13.24 0.001* 1.01 
  Poland (n = 19/18) 18.7 (4.6) 20.2 (5.5) 19.7 (4.4) 20.5 (3.6) 20.2/20.1 0.01 0.92 0.00 
  UK (n = 24/29) 21.7 (3.5) 22.9 (5.1) 22.3 (4.2) 21.0 (4.2) 22.4/20.1 5.50 0.02* 0.68 
 Negative affect Overall (n = 79/67) 27.5 (8.0) 27.1 (8.2) 26.3 (7.6) 25.2 (8.5) 25.8/25.0 1.00 0.32 0.17 
 (11–55) Italy (n = 37/20) 25.8 (7.9) 28.5 (7.4) 23.7 (7.5) 27.3 (8.3) 24.7/25.4 0.40 0.53 0.18 
  Poland (n = 19/18) 31.4 (7.4) 30.9 (7.1) 27.8 (6.9) 28.5 (6.8) 27.6/28.6 0.52 0.48 0.26 
  UK (n = 23/29) 27.2 (8.0) 23.8 (8.4) 29.3 (7.0) 21.8 (8.7) 27.2/21.9 11.57 0.001* 0.99 
 Feelings of Overall (n = 79/63) 10.7 (2.5) 11.2 (2.4) 11.5 (2.5) 10.5 (3.1) 11.5/10.3 7.77 0.01* 0.48 
 belonging Italy (n = 37/20) 11.3 (2.3) 10.7 (2.8) 12.2 (2.2) 10.7 (2.4) 12.8/11.5 4.16 0.05* 0.57 
 (3–15) Poland (n = 19/18) 9.7 (2.7) 10.9 (2.1) 11.2 (2.5) 11.8 (2.2) 11.5/11.4 0.03 0.87 0.06 
  UK (n = 23/25) 10.4 (2.6) 11.8 (2.1) 10.4 (2.8) 9.4 (3.8) 10.4/8.6 3.77 0.06 0.59 
 Overall Overall (n = 81/69) 3.3 (0.8) 3.6 (1.0) 3.3 (0.8) 3.6 (1.0) 3.1/3.4 2.95 0.09# 0.29 
 quality       [2.33] [0.13] [0.26] 
 of life Italy (n = 36/20) 3.5 (0.9) 3.4 (1.1) 3.5 (0.8) 2.8 (0.6) 3.4/2.6 12.74 0.001* 1.00 
 (1–5) Poland (n = 19/18) 3.1 (0.4) 3.8 (1.0) 3.1 (0.4) 3.6 (0.8) 3.1/3.6 5.56 0.02*# 0.82 
        [5.62] [0.02*] 0.83 
  UK (n = 26/31) 3.3 (0.9) 3.6 (1.1) 3.2 (0.9) 4.2 (1.0) 3.1/3.9 14.04 0.00* 1.04 
QOL-AD  Overall 34.8 (5.3) 35.3 (5.1) 35.4 (5.1) 34.6 (5.6) 35.4/34.4 2.24 0.14 0.25 
(range 4–52) (n = 81/67) 
 Italy (n = 37/19) 34.4 (5.5) 32.6 (4.2) 35.0 (5.0) 30.5 (5.8) 35.2/31.7 6.91 0.01* 0.74 
 Poland (n = 19/18) 34.3 (5.2) 37.6 (4.2) 36.3 (5.0) 38.1 (4.4) 37.5/37.1 0.12 0.74 0.13 
 UK (n = 25/30) 35.8 (5.2) 35.7 (5.5) 35.3 (5.3) 35.2 (4.3) 34.8/34.6 0.04 0.85 0.06 
Cornell Scale Overall (n = 80/63) 8.3 (5.6) 6.3 (4.7) 7.8 (5.6) 6.8 (6.1) 6.9/7.3 0.30 0.58 0.09 
Depression Italy (n = 35/16) 6.3 (4.2) 3.8 (2.9) 5.3 (3.5) 5.0 (5.0) 4.3/5.8 1.99 0.17 0.41 
(range 0–38) Poland (n = 19/18) 10.2 (6.1) 7.6 (4.8) 9.4 (6.2) 9.8 (5.5) 8.5/10.5 1.71 0.20 0.45 
UK (n = 26/29) 9.5 (6.3) 6.9 (5.1) 10.2 (6.3) 5.9 (6.6) 8.8/6.4 2.93 0.09 0.48 
NPI Severity Overall (n = 91/72) 9.5 (5.6) 7.8 (5.7) 9.4 (5.6) 8.3 (6.1) 8.9/8.9 0.001 0.98 0.00 
 (range Italy (n = 42/21) 10.8 (6.1) 9.0 (5.5) 10.5 (5.5) 10.2 (4.6) 11.8/11.8 0.01 0.95 0.00 
 0–36) Poland (n = 21/19) 7.2 (3.7) 8.0 (5.5) 6.3 (4.6) 7.8 (6.1) 5.3/6.6 0.63 0.43 0.27 
  UK (n = 28/32) 9.4 (5.7) 6.8 (5.9) 10.1 (5.8) 7.3 (6.8) 8.7/7.9 0.40 0.53 0.17 
DUKe SSI Satisfaction Overall (n = 80/68) 2.9 (0.4) 2.9 (0.4) 2.9 (0.3) 2.9 (0.4) 2.9/2.9 0.31 0.58 0.09 
(range 1–3) Italy (n = 37/20) 2.8 (0.4) 2.8 (0.4) 3.0 (0.2) 2.7 (0.6) 3.0/2.8 2.65 0.11# 0.45 
[2.74] [0.10] [0.46] 
Poland (n = 19/18) 2.8 (0.4) 3.0 (0.0) 2.8 (0.5) 3.0 (0.0) 2.9/2.9 0.33 0.57 0.20 
UK (n = 24/30) 2.9 (0.3) 2.8 (0.5) 3.0 (0.2) 2.9 (0.4) 2.9/2.9 0.06 0.81 0.06 
Help (range Overall (n = 78/66) 14.7 (2.6) 13.8 (2.3) 13.8 (2.1) 13.6 (2.0) 13.5/13.6 0.03 0.87 0.00 
0–24) Italy (n = 34/20) 15.6 (2.6) 14.1 (3.1) 14.3 (1.7) 14.0 (2.1) 13.8/13.8 0.003 0.96 0.00 
Poland (n = 19/18) 15.9 (2.1) 14.9 (1.5) 14.8 (2.3) 14.9 (1.9) 14.6/15.1 0.60 0.44 0.27 
UK (n = 25/28) 12.7 (1.3) 12.9 (1.6) 12.4 (1.7) 12.4 (1.0) 12.4/12.4 0.01 0.93 0.00 
Support (range Overall (n = 82/68) 15.0 (2.8) 14.9 (2.7) 15.7 (2.8) 15.2 (2.6) 15.7/15.1 2.02 0.16# 0.24 
6–18)       [1.68] [0.20] [0.21] 
 Italy (n = 37/20) 15.2 (2.7) 14.8 (2.5) 16.7 (2.0) 15.2 (2.4) 17.0/15.8 3.08 0.09 0.45 
 Poland (n = 19/18) 14.8 (3.3) 16.1 (2.1) 16.2 (3.4) 16.9 (1.8) 16.7/16.4 0.24 0.63 0.17 
 UK (n = 26/30) 14.7 (2.7) 14.3 (3.1) 14.1 (2.7) 14.1 (2.7) 13.9/14.2 0.16 0.69 0.11 
*Significant difference at 95%, P < 0.05. 
#Levene's test showed that the group variances were not equal, so an assumption of covariance analysis was violated (transformed using square root and 
ANCOVA repeated). 
 
3.5 | Country differences 
Italy had the highest attrition rate (36% between pre/post-test com- 
pared with 21% in Poland and 17% in UK). The attrition in the original 
Dutch study was 21%. Participants in the UK MCSP and UC groups 
were more than twice as likely to be male (63% and 64%, respectively) 
than in Italy and Poland where men only accounted for around 32% of 
study participants. The average age was similar across all countries 
(around 78 years). 
Meeting Centres aim to meet the needs of people with mild to 
moderate dementia. The severity of dementia was quantified by GDS 
score, with the expectation that most participants (and thus all 
TABLE 3 Percentage of Meeting Centres Support Programme (MCSP) 
and Usual Care (UC) group participants having symptoms on the NPI at 
pre-test and post-test 
 
MCSP (n = 93) 
 
NPI item Pre-test  Post-test 
UC (n = 74) 
Pre-test  Post-test 
Apathy 68%         70%          57%         66% 
Depression/dysphoria         62%        63%         50%       46% 
Anxiety 63%         63%          62%         62% 
Eating problems 56%         47%          26%         23% 
Agitation/aggression 47%         40%          36%         51% 
UC group rated their overall Quality of Life as better (d = 1.04) than 
the MC group at post-test. The ANCOVAs did not show statistical sig- 
nificant effects on CSDD or NPI on a country level, but there were 
medium effect sizes for Italy regarding improvements in the CSDD 
and DSSI Satisfaction and Support. 
A check on longitudinal changes in possible influencing factors (ill- 
ness, physical disability, psychotropic drugs, use of other types of sup- 
port) between pre and post-test within and between groups, and life 
events within 1 month before the post test, did not reveal differences 
between groups that would have explained the effects found. 
 
Delusions 37% 32% 28% 24% 
Aberrant motor behaviour  38% 34% 28% 32% 4   |   DISCUSSION 
Sleeping disturbances 43% 50% 40% 34%  
Hallucinations 20% 28% 20% 27% This research shows that it is possible to adaptively implement the 
Euphoria 13% 12% 11% 11% Dutch MCSP model in 3 very different European countries and that 
Disinhibition 25% 31% 27% 30% the impact on people living with dementia is broadly comparable to 
     earlier research.4,8 As well as small to medium positive effects on 
research participants) would be GDS stage 4 to 5. The reality was quite 
different and varied across countries (Table 5) with a substantial pro- 
portion of participants having relatively mild cognitive problems but 
also some with severe dementia. The UK had the widest spread of 
11% showing very mild decline and 14% in the severe stages. 
On average, UK MCSP participants with dementia attended 
approximately half the number of days (mean = 34.7 days, SD 15.7) 
as their Polish counterparts (mean = 63.7 days, SD 18.7) and a third 
less than in Italy (mean = 48.1 days, SD 20.9) although individual vari- 
ation was great in all countries. Country specific ANCOVAs (Table 2) 
showed a number of effects on Quality of life between the MCSP 
and UC groups in Italy, Poland, and the UK: Italy achieved large statis- 
tically significant effects on the DQoL sub-domains of Positive Affect 
(d = 1.01) and overall Quality of Life (d = 1.0), and a medium effect 
on Feelings of Belonging (d = 0.57). They also achieved a statistically 
significant medium effect on the QOL-AD (d = 0.74). In Poland, the 
MCSP group rated their overall Quality of life at post-test as lower 
than the UC group (d = 0.83) but compared with pre-test their quality 
of life did not change. In the UK, the MCSP group showed more Posi- 
tive Affect (d = 0.68) at post-test than the UC group (medium effect), 
and a significant improvement on Negative Affect (d = 0.99). The UK 
Self-esteem, the current study also found medium to large effects in 
Positive Affect and a medium effect on Feelings of Belonging. The 
effect on depressed behaviour was not replicated. The original Dutch 
research reported significant decreases in non-social and inactive 
behaviour in the MCSP group. In comparison with these findings, the 
NPI data in the current study did not change significantly overall 
although there were some reductions reported for agitated and 
aggressive behaviour. Apathy increased in both groups but to a greater 
extent in the UC group. The significant correlation between higher 
number of attendances and a greater decrease in neuropsychiatric 
symptoms and greater feelings of support is of particular interest. A 
causal link cannot be attributed to this finding. It may be that those 
with increased severity of symptoms attended less, perhaps because 
their symptoms were disruptive or led to difficulties in them attending. 
Further study of this relationship may be useful in understanding the 
impact of attendance on neuropsychiatric symptom management. 
People living with dementia are a heterogeneous group, and some 
of the differences found may have been due to differences in charac- 
teristics of participants in the current study and the earlier Dutch 
research. Our study was primarily focused on the adaptive implemen- 
tation and validation of the MCSP model. As a consequence, no 
 
TABLE 4  Attendances for research participants over 6 months from pre-test to post-test by country and overall 
 
 N Mean SD Min Max 
Italy      
Person with dementia—days attended MC 39 48.1 20.9 5 79 
Carer hours of attendance 39 18.2 hours 19.8 1 74 
  Poland  
Person with dementia—days attended MC 20 63.7 18.7 3 83 
Carer hours of attendance 20 19.4 hours 47.3 0.5 218.3 
UK      
Person with dementia—days attended MC 28 34.7 15.7 11 63 
Carer hours of attendance 22 65 hours 52.3 2 211.7 
  All countries  
Person with dementia—days attended MC 87 47.4 21.5 3 83 
Irritability/liability 53% 53% 45% 45% 
Carer hours of attendance 81 31.2 hours 43.2 0.5 218.3 
 
TABLE 5  Stage of dementia for Meeting Centres Support Programme and Usual Care participants by country at pre-test 
 
 
MCSP (n = 84)  UC (n = 69)  MCSP (n = 38)  UC (n = 20)  MCSP (n = 19)  UC (n = 18)  MCSP (n = 27)  UC (n = 31) 
Stage 1–2: No or very mild 
cognitive decline 
7 (8.3%) 13 (18.8%) 2 (5.3%) - 2 (10.5%) 4 (22.2%) 3 (11.1%) 9 (29.0%) 
Stage 3: Mild cognitive 21 (25.0%) 9 (13.0%) 13 (34.2%) 1 (5.0%) 6 (31.6%) 4 (22.2%) 2 (7.4%) 4 (12.9%) 
decline 
 
Stage 5: Moderately severe 
cognitive decline 
24 (28.6%) 11 (15.9%) 6 (15.8%) 6 (30.0%) 5 (26.3%) 3 (16.7%) 13 (48.1%) 2 (6.45%) 
 
 
Stage 7: Very severe 
cognitive decline (late 
dementia) 
1 (1.2%) - - - - - 1 (3.7%) - 
 
 
 
 
detailed screening on type of dementia or cognitive impairments was 
performed or taken into account in the analyses, although we 
corrected for between group differences in severity of dementia. In 
the current study, MCSP participants had more severe levels of 
dementia generally than the sample reported by Dröes et al.4 Also, in 
the Dröes et al4 study, those in the UC group generally had a more 
severe dementia than those in the MCSP group, whereas the opposite 
was true in the current study. Within the original Dutch research, the 
UC group consisted of participants of Psychogeriatric Day Care units 
within Nursing homes. This may have impacted on fewer reports of 
apathy, inactivity, and depressive symptoms in the UC group in the 
current study than the original Dutch research. 
The differences between countries in the study results also spoke 
to the heterogeneity of people's experience. Attendance patterns for 
MCs were different across countries. Likewise, the UC comparison 
was not the same in each country. There appeared to be an overall 
correlation between attendance to MCSP and neuropsychiatric symp- 
toms and feelings of being supported. The question of whether higher 
levels of attendance might explain some of the differences in out- 
comes in the different countries is a possibility. It may also have been 
that positive outcomes may have been seen if the MCs had just 
focussed on participants with more similar levels of dementia such as 
the GDS 4/5. The MCs were established over a relatively short period 
of time, and it may have taken a greater amount of time for the model 
to bed into the new countries. All these issues may have diluted the 
effect. The study was not sufficiently powered to test this by within 
country analysis. 
This was an exploratory study of a complex intervention in 3 coun- 
tries that required significant commitment from people to participate. 
The attrition rate of 27% in the MC group was quite high compared 
with other psycho-social interventions. In the original multicentre 
study in the Netherlands, attrition was 20% between pre and post-test. 
This lower attrition might also be because the Dutch sample had less 
severe dementia (50% had mild dementia in the Dutch sample). 
The study had a number of limitations in evaluating the impact of 
the intervention on people living with dementia. Allocation to the inter- 
vention was not random. In order to recruit enough participants to the 
intervention group, it was necessary to compare to a geographical con- 
trol group where there was not a MC. Assessors were not blind to the 
GDS Stage (Reisberg) All Countries Italy Poland UK 
 
decline 
27 (32.1%) 33 (47.8%)   5 (18.5%) 14 (45.2%) 
 
 
     
 
intervention that participants received. Baseline measurements 
took place up to 1 month after commencing at the MC. Only 
participants that completed 6 months of attendance were included in 
the analyses. The analysis also undertook numerous tests of 
significance and multiple comparisons. However, the current study 
was designed primarily as an implementation study where much of 
the time and energy was put in realising at least 2 MCs in each 
country who provided the full MCSP12,13 were piloted and evaluated. 
Consequently, larger samples with blind assessment were not 
possible in this study. For a thorough effect study per country, 
separate larger sized RCTs would be required. 
Despite these challenges, we were able to replicate a 
successful intervention from 1 country into 3 others and found 
significant benefits. This study demonstrated that cross-country 
and multicentre evaluations of psychosocial interventions are 
feasible. There may be many other interventions that could be 
implemented between countries to improve the post-diagnostic 
support for people with dementia on a more global scale. 
Specifically, this study suggests that the MCSP model can be 
successfully implemented in countries with very different health and 
social care systems. This should encourage other countries to 
implement this model with country specific adaptation. Overall, 
the intervention was delivered as planned, and the evaluation was 
carried out in a standardized way. Sufficient numbers of 
participants were recruited across 3 different countries to conduct a 
sufficiently powered overall effect analysis. There was variance both 
within but also between countries in patterns of attendance in the 
different countries, which may have diluted the effect of the impact 
of the intervention on a group level and as a consequence decreased 
some of the overall benefits. 
The results of our study are in line with the literature on interven 
tions supporting community dwelling people to live with dementia 
and to improve their social participation, thus aiming to improve their 
social health and quality of life.30 Examples are: home community 
occupa-tional therapy31,32; the Enriched Opportunities 
Programme33; inter- generational programmes34; and easy access 
day treatment centres for people with dementia with carer 
support.35 This current study is part of the emerging research into 
psychosocial interventions that report on positive outcomes rather 
than just reporting on the reduc- tion of negative symptoms.36 It 
also shows the strength of combining interventions for people 
living with dementia and caregivers to bring about clinically relevant 
improvements in well-being. 
 
5   |   CONCLUSION 
 
This study answered 2 main questions: Does the successful MCSP 
model developed in the Netherlands work in other European countries, 
more specifically in Italy, Poland, and the UK, and are comparable ben- 
efits achieved for people with dementia and their carers in these coun- 
tries? The present study showed this to be the case, the 
implementation proved successful in all 3 countries, and the benefits 
were partially replicated. Further dissemination of MCSP is therefore 
recommended within the countries involved in the study, but also in 
other European countries and beyond. There is a great need for high 
quality implementation research to demonstrate how care interven- 
tions can be put into practice in a variety of settings and how evi- 
dence-based practices can be effectively disseminated and 
transferred to other countries to share knowledge and improve 
dementia care on a European and world wide level. Demonstrating 
that outcomes of effective interventions in 1 country can be replicated 
in other countries is therefore very important. 
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